PFIZER, INC.

(PFE)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 05/24 03:14:03 pm
53.385 USD   +0.95%
12:13pGLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
10:48aWALL STREET STOCK EXCHANGE : Snap cut the rally short
10:36aMarketScreener's World Press Review : May 24, 2022
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

WHO, EMA Warn Against Repeated COVID-19 Booster Shots

01/13/2022 | 04:59am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE -5.20% 154.72 Delayed Quote.-36.69%
MODERNA, INC. -4.66% 131.21 Delayed Quote.-45.81%
ON SEMICONDUCTOR CORPORATION -2.97% 54.26 Delayed Quote.-17.71%
PFIZER, INC. 0.70% 53.26 Delayed Quote.-10.45%
All news about PFIZER, INC.
12:13pGLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
10:48aWALL STREET STOCK EXCHANGE : Snap cut the rally short
10:36aMarketScreener's World Press Review : May 24, 2022
06:47aPfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-..
BU
05:26aPfizer Sees Positive Results in Etrasimod Trials
DJ
01:08aChina's bet on homegrown mRNA vaccines holds back nation
AQ
05/23Pfizer says 3 COVID shots protect children under 5
AQ
05/23Wall Street rebounds with assist from banks, big tech
RE
05/23What's next for COVID-19 vaccines for youngest US children
AQ
05/23GLOBAL MARKETS LIVE : Tesla, Kohl's, Apple, JPMorgan, Bank of America...
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 662 M - -
Net cash 2022 10 478 M - -
P/E ratio 2022 8,82x
Yield 2022 3,07%
Capitalization 297 B 297 B -
EV / Sales 2022 2,75x
EV / Sales 2023 3,58x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 52,88 $
Average target price 57,66 $
Spread / Average Target 9,04%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-10.45%296 704
JOHNSON & JOHNSON4.89%472 179
ROCHE HOLDING AG-14.40%273 052
ELI LILLY AND COMPANY9.55%272 388
ABBVIE INC.9.33%261 585
NOVO NORDISK A/S2.29%245 087